CME Group accounting chief reports 2,112-share holding

CME Group Inc. reports that Matthew V. Render, MD, Chief Accounting Officer, directly held 2,112 shares of Common Stock Class A as of November 2, 2026.

Available on EDGAR 11/02/2026 - 07:57 PM EST Accepted by SEC EDGAR 11/02/2026 - 07:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CME Group Inc. reports that Matthew V. Render, MD, Chief Accounting Officer, directly held 2,112 shares of Common Stock Class A as of November 2, 2026.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Render Matthew V

Role MD, Chief Accounting Officer

Type	Security	Shares	Price	Value
Holding	Common Stock Class A	--	--	--

Holdings: Common Stock Class A — 2,112 shares (Direct)

Key Figures

Directly held shares: 2,112 shares

1 metrics

Directly held shares 2,112 shares Common Stock Class A, as of November 2, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CME shares did Matthew V. Render report?

Matthew V. Render, CME Group’s MD, Chief Accounting Officer, reported direct ownership of 2,112 shares of Common Stock Class A as of November 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Render Matthew V

(Last) (First) (Middle)

20 S. WACKER DR.

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
11/02/2026

3. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	MD, Chief Accounting Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock Class A	2,112	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for Matthew V. Render	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)